Literature DB >> 1777883

Relevance of removal of limbic structures in surgery for temporal lobe epilepsy.

A Olivier1.   

Abstract

We have briefly reviewed the experimental and clinical evidence for the importance of the amygdala and hippocampal formation in temporal lobe epilepsy. More specifically, we have analyzed our own experience in patients with temporal lobe epilepsy investigated with intracerebral stereotaxic electrodes and operated by various modalities of resection. Our results, in agreement with previous experimental and clinical work, provide further evidence for an overwhelming predominance of limbic participation in temporal lobe epilepsy. As a result, more and more selective procedures are being carried out involving the mesial structures. However, this shift has been slow and progressive because of the proven value of cortico-amygdalo-hippocampectomy which provides excellent results on seizure tendency with low morbidity.

Entities:  

Mesh:

Year:  1991        PMID: 1777883     DOI: 10.1017/s0317167100032844

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  4 in total

1.  Perfusion patterns in postictal 99mTc-HMPAO SPECT after coregistration with MRI in patients with mesial temporal lobe epilepsy.

Authors:  R E Hogan; M J Cook; D W Binns; P M Desmond; C J Kilpatrick; V L Murrie; K F Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

2.  Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients.

Authors:  J Zentner; A Hufnagel; H K Wolf; B Ostertun; E Behrens; M G Campos; L Solymosi; C E Elger; O D Wiestler; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

Review 3.  Surgical Considerations of Intractable Mesial Temporal Lobe Epilepsy.

Authors:  Warren W Boling
Journal:  Brain Sci       Date:  2018-02-20

4.  Selective amygdalohippocampectomy.

Authors:  David Spencer; Kim Burchiel
Journal:  Epilepsy Res Treat       Date:  2011-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.